PETACH TIKVA, Israel — September 17, 2025 — Leads & Copy — PolyPid Ltd. (Nasdaq: PYPD) announced that its management will present at the Lytham Partners Fall 2025 Virtual Investor Conference on September 30, 2025, and participate in the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025.
Management will present at the Lytham Partners conference during a fireside chat with Craig-Hallum Senior Research Analyst, Chase Knickerbocker, at 4:15 p.m. ET and will be available for one-on-one virtual meetings. The webcast can be accessed at https://lythampartners.com/fall2025/ or directly at https://app.webinar.net/LnVaeQkg6b0. A replay will be available following the event. To arrange a meeting, contact Lytham Partners at 1×1@lythampartners.com or register at https://lythampartners.com/fall2025invreg/.
At the ROTH Healthcare Opportunities Conference, management will participate in one-on-one meetings. Investors interested in meeting with PolyPid should contact their ROTH representative.
PolyPid Ltd. (Nasdaq: PYPD) is a biopharma company aiming to improve surgical outcomes through locally administered, controlled, prolonged-release therapeutics. Its PLEX (Polymer-Lipid Encapsulation matriX) technology enables precise drug delivery. The company expects to submit a New Drug Application (NDA) for D-PLEX₁₀₀, its lead product candidate, in early 2026, for the prevention of abdominal colorectal surgical site infections. PolyPid also has an innovative pipeline in oncology, obesity, and diabetes.
Contact: Ori Warshavsky, 908-858-5995, IR@Polypid.com
Source: PolyPid Ltd.
